Genmab ( ($GMAB) ) has provided an update. On November 20, 2025, Genmab A/S announced the grant of 6,933 restricted stock units and 7,377 warrants ......

Genmab ( ($GMAB) ) just unveiled an update. On November 19, 2025, Genmab A/S announced transactions involving shares and linked securities conducte......

Genmab ( ($GMAB) ) has provided an announcement. Genmab A/S has updated its Articles of Association, authorizing the Board of Directors to increase......

The latest announcement is out from Genmab ( ($GMAB) ). On November 18, 2025, Genmab A/S announced a capital increase of 32,059 shares following th......

Genmab ( ($GMAB) ) just unveiled an update. On November 18, 2025, Genmab A/S announced that the U.S. FDA approved EPKINLY® (epcoritamab-bysp) in co......

In a report released on November 14, Jon Berggren from Kepler Capital maintained a Hold rating on Genmab A/S, with a price target of DKK2,100.00. T......

Several pharmaceutical companies awaiting a decision from U.S. authorities on their drug applications are set to get them this month. These decisio......

UBS analyst Xian Deng maintained a Buy rating on Genmab A/S on November 7 and set a price target of DKK2,700.00. The company’s shares closed yester......

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Genmab (GMAB – Research Report), Aziyo Biologics (ELUT – Research......

Genmab ( ($GMAB) ) has issued an announcement. On November 6, 2025, Genmab announced its financial results for the first nine months of 2025, repor......